Tuesday, June 04, 2019 6:42:59 PM
ISCO isn't a scam company. They have two subsidiaries bringing in revenue. But, research and trials are very expensive. Cost is why many companies are running clinical trials in Australia. Go to the links I've provided rather than just reading the titles.
I'm sure you've heard of astrazeneca. Here's their take on doing trials in Australia.
https://www.astrazeneca.com.au/sustainability/About-us-research-development.html
In partnership with doctors in Australia we focus our skills and resources on getting life-changing medicines to patients as quickly, safely and efficiently as possible. We are currently conducting research to develop new medicines in the following disease areas:
To find out more about clinical trials in Australia, please visit the dedicated Australian Government website www.australianclinicaltrials.gov.au
**********
HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2019/04/29/AUSTRALIA-S-CLINICAL-TRIALS-INDUSTRY-IS-EXPERIENCING-UNPRECEDENTED-SUPPORT
Australia’s clinical trials industry is experiencing ‘unprecedented support’
29-Apr-2019 By Melissa Fassbender
The Australian Government commits $100m to support rural, regional, and remote clinical trials – recognizing the importance of a “vibrant clinical trial ecosystem in underpinning a world-class health care system,” says industry expert.
**********
Australia: Preferred Destination for Early Phase Clinical Trials
https://ww3.frost.com/files/6514/7374/3781/Novotech_WP_20160701_v2.1.pdf
**********
As I said earlier, dilution has been the main problem here. Not unheard of in biotech. Biotech is very risky for early investors and I got involved way too early with this one. But, that is my fault, not the company's fault. It's been off my radar for awhile now, but, I'm watching again for the upcoming trial results.
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent ISCO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:00:37 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:35:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:29:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 10:18:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:00:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2025 01:57:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 12:21:17 PM
